低复杂度筛查试验在社区结核病病例发现中的成本效果
研究建立微模拟模型,在结核患病率为国家估计4倍的假设人群中评估三种社区病例发现策略。普遍Xpert Ultra每避免一个DALY成本为670至2000美元;CRP策略成本较低但避免的DALY减少44%;假想筛查试验需提高灵敏度和特异度且降低成本才具成本效果。
要点
- 普遍Xpert Ultra每10万人筛查避免3200个DALY,每避免一个DALY成本670至2000美元。
- CRP策略每避免一个DALY成本550至1500美元,但避免的DALY减少44%。
- 假想筛查试验若特异度提至95%且单次成本4.5美元,每避免一个DALY成本390至940美元。
核心结论
- 筛查试验可有意义地改善社区结核病例发现的成本效果,但前提是试验具有高灵敏度、高特异度且价格低廉。
研究设计与样本
- 微模拟模型评估三种社区病例发现策略,假设人群结核患病率为国家估计的4倍。
- 假设场景类似印度、南非、菲律宾、乌干达和越南,成本以2023年美元表示并包含治疗费用。
- 评估策略包括:床旁C反应蛋白(CRP)筛查、假想筛查试验(对Xpert Ultra阳性结核灵敏度95%、特异度70%,设备/人力成本类似Xpert Ultra但试剂盒2美元)阳性后痰Xpert Ultra、以及所有人痰Xpert Ultra检测。
主要发现
- 普遍Xpert Ultra每避免一个DALY成本从菲律宾的670美元至越南的2000美元。
- CRP策略每避免一个DALY成本从菲律宾的550美元至越南的1500美元,但避免的DALY减少44%。
- 假想筛查试验相比普遍Xpert Ultra获益极小;若特异度提高至95%且单次总成本4.5美元,每避免一个DALY成本从菲律宾的390美元至越南的940美元。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In high-burden settings, low-complexity screening tests for tuberculosis (TB) could expand the reach of community-based case-finding efforts. The potential costs and cost-effectiveness of approaches incorporating these tests are poorly understood. METHODS: We developed a microsimulation model assessing 3 approaches to community-based case-finding in hypothetical populations (India-, South Africa-, The Philippines-, Uganda-, and Vietnam-like settings) with TB prevalence 4 times that of national estimates: (1) screening with a point-of-care C-reactive protein (CRP) test, (2) screening with a more sensitive "Hypothetical Screening test" (95% sensitive for Xpert Ultra-positive TB, 70% specificity; equipment/labor costs similar to Xpert Ultra, but using a $2 cartridge) followed by sputum Xpert Ultra if positive, or (3) testing all individuals with sputum Xpert Ultra. Costs are expressed in 2023 US dollars and include treatment costs. RESULTS: Universal Xpert Ultra was estimated to cost a mean $4.0 million (95% uncertainty range: $3.5 to $4.6 million) and avert 3200 (2600 to 3900) TB-related disability-adjusted life years (DALYs) per 100 000 people screened ($670 [The Philippines] to $2000 [Vietnam] per DALY averted). CRP was projected to cost $550 (The Philippines) to $1500 (Vietnam) per DALY averted but with 44% fewer DALYs averted. The Hypothetical Screening test showed minimal benefit compared to universal Xpert Ultra, but if specificity were improved to 95% and per-test cost to $4.5 (all-inclusive), this strategy could cost $390 (The Philippines) to $940 (Vietnam) per DALY averted. CONCLUSIONS: Screening tests can meaningfully improve the cost-effectiveness of community-based case-finding for TB but only if they are sensitive, specific, and inexpensive.
引用
- Brümmer LE, Thompson RR, Malhotra A, et al. Cost-effectiveness of Low-complexity Screening Tests in Community-based Case-finding for Tuberculosis. Clin Infect Dis. 2024. PMID: 37623745. doi:10.1093/cid/ciad501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。